WallStreetZenWallStreetZen

NASDAQ: GOSS
Gossamer Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GOSS

Based on 5 analysts offering 12 month price targets for Gossamer Bio Inc.
Min Forecast
$4.00+476.37%
Avg Forecast
$8.60+1,139.19%
Max Forecast
$15.00+2,061.38%

Should I buy or sell GOSS stock?

Based on 5 analysts offering ratings for Gossamer Bio Inc.
Strong Buy
Strong Buy
2 analysts 40%
Buy
3 analysts 60%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GOSS stock forecasts and price targets.

GOSS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-08
lockedlocked$00.00+00.00%2024-05-06
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2024-03-06

1 of 1

Forecast return on equity

Is GOSS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.27%

Forecast return on assets

Is GOSS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GOSS revenue forecast

What is GOSS's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$160.0M
Avg 2 year Forecast
$29.2M
Avg 3 year Forecast
$82.5M

GOSS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GOSS$0.69$8.60+1,139.19%Strong Buy
MDWD$16.98$28.00+64.90%Buy
XFOR$0.93$3.00+223.28%Buy
CRDF$3.63$10.50+189.26%Strong Buy
RPTX$3.55$10.00+181.69%Buy
View Top Biotech Stocks

Gossamer Bio Stock Forecast FAQ

Is Gossamer Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: GOSS) stock is to Strong Buy GOSS stock.

Out of 5 analysts, 2 (40%) are recommending GOSS as a Strong Buy, 3 (60%) are recommending GOSS as a Buy, 0 (0%) are recommending GOSS as a Hold, 0 (0%) are recommending GOSS as a Sell, and 0 (0%) are recommending GOSS as a Strong Sell.

If you're new to stock investing, here's how to buy Gossamer Bio stock.

What is GOSS's revenue growth forecast for 2024-2026?

(NASDAQ: GOSS) Gossamer Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Gossamer Bio's revenue in 2024 is $0.On average, 3 Wall Street analysts forecast GOSS's revenue for 2024 to be $36,194,984,320, with the lowest GOSS revenue forecast at $36,194,984,320, and the highest GOSS revenue forecast at $36,194,984,320. On average, 1 Wall Street analysts forecast GOSS's revenue for 2025 to be $6,605,584,638, with the lowest GOSS revenue forecast at $6,605,584,638, and the highest GOSS revenue forecast at $6,605,584,638.

In 2026, GOSS is forecast to generate $18,654,668,700 in revenue, with the lowest revenue forecast at $6,537,719,043 and the highest revenue forecast at $34,744,922,761.

What is GOSS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GOSS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is GOSS's Price Target?

According to 5 Wall Street analysts that have issued a 1 year GOSS price target, the average GOSS price target is $8.60, with the highest GOSS stock price forecast at $15.00 and the lowest GOSS stock price forecast at $4.00.

On average, Wall Street analysts predict that Gossamer Bio's share price could reach $8.60 by May 8, 2025. The average Gossamer Bio stock price prediction forecasts a potential upside of 1,139.19% from the current GOSS share price of $0.69.

What is GOSS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GOSS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.